FILTER
FILTERED INTERVIEW RESULTS
Tim Swendseid
PRESIDENT, ELEVATION GOLD MINING
"The areas next to the Moss pit are really prospective for finding more gold."
Sydney Hay
PRESIDENT, AMIGOS
"What might have been considered waste 25 years ago is being commercially mined today, and this is only going to get better."
Jeff Luber
CEO, BINX HEALTH, INC.
"Certainly, the way healthcare is consumed has changed forever with people looking for convenient on-site and at-home solutions for care and we see this accelerating."
Peter Soelkner
MANAGING DIRECTOR, VETTER PHARMA INTERNATIONAL
"Our mission will remain to provide reliable, efficient, and safe processes from development, aseptic filling, and visual inspection to parenteral packaging in an economically, ethically, and ecologically responsible manner."
Steve Trussell
PRESIDENT, ARIZONA MINING ASSOCIATION
"We work very well with the Arizona agencies, the administration, and our state legislature, as they absolutely understand the importance of mining in the state of Arizona."
Jeffrey Nau
PRESIDENT & CEO, OYSTER POINT PHARMA
"Our mission is to bring novel and transformative therapies to the anterior (front) chamber of the eye, particularly for the treatment of ocular surface disease."
Shuang Liu
CEO & FOUNDER, CONSYNANCE THERAPEUTICS
"Although each rare disease impacts a small population, the rare disease population is estimated to be 10% of the total population, meaning 25-30 million Americans have at least one rare condition."
Jay Roberts & Robert Fremeau
PRESIDENT AND CEO & CHIEF SCIENTIFIC OFFICER, VYANT BIO
"At Vyant Bio we are reinventing how drugs are discovered for complex neurological and neurodegenerative disorders by applying a human-first approach."
Andrea Pfeifer
CO-FOUNDER & CEO, AC IMMUNE
"AC Immune is combining diagnostics and therapeutics, and it has developed the tools to enable detection and clearance of specific pathological proteins underlying neurodegenerative diseases."
Trevor P. Castor
PRESIDENT & CEO, APHIOS CORPORATION
"In 2021, we focused on introducing our green pathogen reduction technology to biotechnology and pharmaceutical companies."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Latin America Petrochemicals and Chemicals 2024 - Digital Interactive
The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.
The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
